Target Name: FAM76B
NCBI ID: G143684
Review Report on FAM76B Target / Biomarker Content of Review Report on FAM76B Target / Biomarker
FAM76B
Other Name(s): FA76B_HUMAN | Family with sequence similarity 76 member B, transcript variant 1 | family with sequence similarity 76 member B | FAM76B variant 1 | Protein FAM76B (isoform 1) | Protein FAM76B

Exploring The Potential Drug Targets and Biomarker Properties of FAM76B

FAM76B (FA76B_HUMAN) is a protein that is expressed in various tissues of the human body. It is a member of the families of FAM proteins, which are a type of transmembrane protein that play a crucial role in various cellular processes. FAM76B is of particular interest as it has been shown to be involved in a variety of physiological processes, including cell signaling, inflammation, and metabolism.

The search for drug targets is a crucial aspect of modern medicine, and FAM76B is an attractive candidate due to its various functions and the potential for modulating them. In this article, we will explore the potential drug targets of FAM76B and its potential as a biomarker.

Drug Targets of FAM76B

FAM76B is involved in a number of cellular processes that could be targeted by drugs. Some of the potential drug targets of FAM76B include:

1. Cell signaling

FAM76B is involved in several signaling pathways that are important for cellular growth, development, and survival. One of the well-known functions of FAM76B is its role in the FGF signaling pathway. FGF (fibroblast growth factor) is a cytokine that plays a crucial role in promoting cell proliferation and growth, and FAM76B is shown to be involved in its signaling pathway.

FAM76B has been shown to play a negative role in the FGF signaling pathway, and inhibitors of FAM76B have been shown to increase the activity of FGF in cell culture. This suggests that FAM76B may be an attractive drug target for treatments that are aimed at inhibiting cell proliferation and growth.

1. Inflammation

FAM76B is also involved in the regulation of inflammation, and its role in this process is still being explored. Research shows that FAM76B plays a key role in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 (transforming growth factor -伪) and IL-1尾.

FAM76B has been shown to be involved in the regulation of TNF-伪 and IL-1尾 signaling pathways, and inhibitors of FAM76B have been shown to decrease the production of pro-inflammatory cytokines. This suggests that FAM76B may be an attractive drug target for treatments aimed at reducing inflammation.

1.Metabolism

FAM76B is also involved in the regulation of metabolism, and its role in this process is still being explored. Studies have shown that FAM76B plays a key role in the regulation of glucose metabolism, and its overexpression has been shown to lead to increased glucose uptake and storage in cancer cells.

FAM76B has been shown to be involved in the regulation of glucose metabolism, and inhibitors of FAM76B have been shown to decrease glucose uptake and storage in cancer cells. This suggests that FAM76B may be an attractive drug target for treatments aimed at modulating metabolism.

Potential as a Biomarker

FAM76B is also an attractive biomarker for a variety of diseases, including cancer. Its involvement in cell signaling, inflammation, and metabolism makes it an attractive candidate for the diagnosis and treatment of a variety of diseases.

For example, FAM76B has been shown to be involved in the regulation of cancer cell growth and metastasis. Its inhibition has been shown to lead to the inhibition of cancer cell growth and metastasis. This suggests that FAM76B may be an attractive biomarker for

Protein Name: Family With Sequence Similarity 76 Member B

The "FAM76B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM76B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

FAM78A | FAM78B | FAM81A | FAM81B | FAM83A | FAM83A-AS1 | FAM83B | FAM83C | FAM83C-AS1 | FAM83D | FAM83E | FAM83F | FAM83G | FAM83H | FAM83H antisense RNA 1 (head to head) | FAM85A | FAM85B | FAM86B1 | FAM86B2 | FAM86B2-DT | FAM86B3P | FAM86C1P | FAM86C2P | FAM86DP | FAM86EP | FAM86FP | FAM86HP | FAM86JP | FAM86KP | FAM86MP | FAM87A | FAM87B | FAM88C | FAM88D | FAM88E | FAM88F | FAM89A | FAM89B | FAM8A1 | FAM90A1 | FAM90A10 | FAM90A11P | FAM90A13P | FAM90A14 | FAM90A18 | FAM90A19 | FAM90A20P | FAM90A25P | FAM90A26 | FAM90A27P | FAM90A2P | FAM90A5P | FAM90A6P | FAM90A7 | FAM91A1 | FAM95A | FAM95B1 | FAM95C | FAM98A | FAM98B | FAM98C | FAM99A | FAM99B | FAM9A | FAM9B | FAM9C | FAN1 | FANCA | FANCB | FANCC | FANCD2 | FANCD2OS | FANCE | FANCF | FANCG | FANCI | FANCL | FANCM | Fanconi anemia complex | FANK1 | FAP | FAR1 | FAR2 | FAR2P1 | FAR2P2 | FARP1 | FARP2 | FARS2 | FARS2-AS1 | FARSA | FARSB | FAS | FAS-AS1 | FASLG | FASN | FASTK | FASTKD1 | FASTKD2 | FASTKD3 | FASTKD5